Table 4. Quality Assessment of the Nine Included Studies.
Newcastle-Ottawa Scale* | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Author | 1 | 2 | 3 | 4 | 5A | 5B | 6 | 7 | 8 | Total |
Wang | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | 8 |
Imran | Yes | Yes | Yes | Yes | No | No | Yes | No | Yes | 6 |
Bae | Yes | Yes | Yes | Yes | No | Yes | Yes | No | Yes | 7 |
Wu | Yes | Yes | Yes | Yes | No | No | Yes | No | Yes | 6 |
Chung | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | 7 |
Larsson | Yes | Yes | Yes | Yes | No | Yes | Yes | No | Yes | 7 |
Lancaster | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | 7 |
Kharaghani | Yes | Yes | No | Yes | Yes | Yes | No | Yes | Yes | 7 |
Kim | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | 8 |
Vollebregt | Yes | Yes | Yes | Yes | No | No | Yes | Yes | Yes | 7 |
Qiu | Yes | Yes | No | Yes | Yes | No | No | Yes | Yes | 6 |
Kurki | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | 8 |
*1 indicates case definition or ascertainment of exposure; 2, representativeness of the cases or exposed cohort; 3, selection of controls or non-exposed cohort; 4, description of the control source or demonstration of outcome of interest in cohort; 5A, based on the most important factor to select and study controls; 5B, based on a second crucial factor to select and study controls; 6, assessment of exposure or outcome by blinded interview or record; 7, same method of ascertainment used for cases and controls or adequate follow-up period; 8, evenly distributed non-response rate or adequacy of follow-up of cohorts